Having recently scored approval for Nucala in chronic obstructive pulmonary disease (COPD), GSK has now signed a major ...

A recent Veterans Health Administration (VHA) study published in the Journal of American Medical Association revealed that switching from metered-dose inhalers (MDIs) to dry-powder inhalers (DPIs) ...

This case underscores two critical lessons: first, pulmonary mucormycosis should be considered in patients with steroid-treated COPD with nodules mimicking malignancy, regardless of immune status.

We came across a bullish thesis on Verona Pharma plc (VRNA) on Capital Employed’s Substack by Patients Capital Management. In ...

Patients with acute asthma treated in the emergency department (ED) are frequently treated with inhaled beta 2 -agonists and systemic corticosteroids after discharge. The use of inhaled ...

Fixed-dose combination inhalers containing both a steroid and a fast-acting beta₂-agonist (FABA) in the same device simplify inhalers regimens and ensure symptomatic relief is accompanied by ...

Merck has entered a definitive agreement to acquire biopharmaceutical company Verona Pharma in a deal valued at $10bn.

Asthma is the most common chronic disease of childhood. Acute asthma attacks are a frequent reason for emergency presentation in children and young people (CYP), and fatal asthma attacks can occur ...

Digital inhalers may help predict occurrence of acute exacerbations of COPD for patients in an ambulatory setting.